Mercer Global Advisors
AGN

Mercer Global Advisors’s Allergan plc AGN Stock Holding History

Mercer Global Advisors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,500
Closed -$797K – 1222
2020
Q1 		$797K Sell
4,500
-11,748
-72% -$2.21M 0.02% 543
2019
Q4 		$3.11M Sell
16,248
-933
-5% -$168K 0.06% 251
2019
Q3 		$2.89M Buy
17,181
+604
+4% +$98.4K 0.07% 230
2019
Q2 		$2.78M Sell
16,577
-807
-5% -$112K 0.07% 215
2019
Q1 		$2.54M Buy
+17,384
New +$2.52M 0.09% 194

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Mercer Global Advisors's AGN Position: Q2 2020 in Review

Mercer Global Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,500 shares — an estimated $797K sold.

Mercer Global Advisors first reported a position in AGN in Q1 2019 and held it in 5 quarters. The position peaked at $3.11M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Mercer Global Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Mercer Global Advisors sold 4,500 Allergan plc shares in Q2 2020, an estimated $797K.
  • Mercer Global Advisors first reported a position in Allergan plc in Q1 2019 and held it in 5 quarters.
  • Mercer Global Advisors's Allergan plc position peaked at $3.11M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Mercer Global Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.